Indivior PLC Ordinary Shares (INDV) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Indivior Pharmaceuticals, Inc.

Total Revenue Chart for Indivior PLC Ordinary Shares

Indivior PLC Ordinary Shares (INDV) revenue for FY2025 was USD 1.2B, a 4.3% change from FY2024. Indivior PLC Ordinary Shares's revenue grew from USD 968.9M in 2016 to USD 1.2B in 2025 (27.9% over 9 years). Earnings per share grew from USD 0.89 in 2019 to USD -0.38 in 2022 (-143.0%). Revenue compound annual growth rate: 5-year CAGR of 13.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.17B
Implied Share Price
$35.37
Enterprise Value
$4.37B
Revenue (TTM)
$1.37B
EBITDA
$652.00M
Profit Margin
32.75%
Trailing P/E
9.91
Forward P/E
9.21
Price/Book (MRQ)
145.25
Price/Sales (TTM)
3.04
EV/EBITDA
7.70
EV/Revenue
3.18
Dividend Yield
—
Book Value
$-0.51
Free Cash Flow (FY2025)
-$94.00M
Free Cash Flow Yield
-2.25%

Snapshot as of 31st October 2026 — not point-in-time controlled, may lag the live market by a few days.